A Phase I/II, Randomized, Placebo-controlled, Double-masked, Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers
Latest Information Update: 29 Sep 2022
At a glance
- Drugs Chloroprocaine (Primary)
- Indications Anaesthesia
- Focus Registrational; Therapeutic Use
- Sponsors Sintetica
- 27 Sep 2022 According to a Harrow Health media release, the U.S. Food and Drug Administration (FDA) has approved IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% for ocular surface anesthesia, based on results from NCT04753710, NCT04685538 and NCT04779606.
- 05 Mar 2021 New trial record